Deciphera Pharmaceuticals’ $135.1 Million Common Stock Offering

Pietro Martinoia
Tagged:

Goodwin Procter advised Deciphera Pharmaceuticals, and Davis Polk advised the joint book-running managers involved in the offering.Deciphera Pharmaceuticals Inc. announced a $135.1 million SEC-registered common stock offering….

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now